BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 3956945)

  • 1. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
    Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
    Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hepatitis B virus deoxyribonucleic acid, HBeAg/anti-HBe status in serum and HBcAg in liver: its clinical significance in chronic HBsAg carriers.
    Kiyosawa K; Nakamura M; Sodeyama T; Tanaka E; Nakano Y; Furuta S
    Jpn J Med; 1988 Aug; 27(3):267-71. PubMed ID: 3057267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
    J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
    Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
    J Clin Microbiol; 1992 May; 30(5):1111-9. PubMed ID: 1583107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic lymphocyte subpopulation defined by monoclonal antibodies in anti-HBe positive type B chronic active hepatitis.
    Yamada G; Hyodo I; Nishihara T; Nagashima H
    Gastroenterol Jpn; 1985 Oct; 20(5):441-6. PubMed ID: 4076728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.
    Karayiannis P; Fowler MJ; Lok AS; Greenfield C; Monjardino J; Thomas HC
    J Hepatol; 1985; 1(2):99-106. PubMed ID: 2997321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
    Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
    J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].
    Thiers V; Bouchardeau F; Courouce AM; Tiollais P; Brechot C
    Presse Med; 1986 Jun; 15(26):1219-22. PubMed ID: 2944091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
    Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
    Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Su IJ; Lai MY; Hsu HC; Chen DS; Yang PM; Chuang SM; Sung JL
    J Hepatol; 1986; 3(2):182-9. PubMed ID: 3794299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers.
    Rabbi FJ; Rezwan MK; Shirin T
    Bangladesh Med Res Counc Bull; 2008 Aug; 34(2):39-43. PubMed ID: 19119537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B. Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum.
    Lindh G
    Scand J Infect Dis Suppl; 1986; 50():1-45. PubMed ID: 3468608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.
    Lok AS; Hadziyannis SJ; Weller IV; Karvountzis MG; Monjardino J; Karayiannis P; Montano L; Thomas HC
    Gut; 1984 Nov; 25(11):1283-7. PubMed ID: 6500366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous reactivation of hepatitis B virus replication in HBsAg carriers who seroconverted from HBeAg to anti-HBe.
    Okuno T; Takeda M; Matsumoto M; Shindo M; Arai K; Takino T
    Jpn J Med; 1989; 28(1):45-9. PubMed ID: 2724647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.
    Okamoto H; Yotsumoto S; Akahane Y; Yamanaka T; Miyazaki Y; Sugai Y; Tsuda F; Tanaka T; Miyakawa Y; Mayumi M
    J Virol; 1990 Mar; 64(3):1298-303. PubMed ID: 2304145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.